Discover
INKT
MiNK Therapeutics, Inc.
12.05
2 x 8.64
2 x 15.36
bid
ask
+
0.41
3.49%
2 @ 07:30 PM
12.25 +0.20 (1.66%)
| Ytd | 8.07% | |
| 1y | -21.50% |
11.70
day range
12.08
8.56
52 week range
16.30
| Open | 11.99 | Prev Close | 11.64 | Low | 11.70 | High | 12.08 | Mkt Cap | 61.49M |
| Vol | 18.91K | Avg Vol | 12.48K | EPS | -2.37 | P/E | N/A | Forward P/E | -1.17 |
| Beta | 0.05 | Short Ratio | 1.10 | Inst. Own | 2.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 11.23 | 200-d Avg | 11.40 | 1yr Est | 6.50 |
| Income Statement | |||
| Operating Expenses | 3.22M | ||
| Research and Development Expense | 1.89M | ||
| Selling, General and Administrative Expense | 1.33M | ||
| Operating Income | -3.22M | ||
| Net Income | -3.13M | ||
| Net Income Common Stock | -3.13M | ||
| Net Income Common Stock (USD) | -3.13M | ||
| Consolidated Income | -3.13M | ||
| Earnings per Basic Share | -0.62 | ||
| Earnings per Basic Share (USD) | -0.62 | ||
| Earnings per Diluted Share | -0.62 | ||
| Earning Before Interest & Taxes (EBIT) | -3.13M | ||
| Earning Before Interest & Taxes (USD) | -3.13M | ||
| Weighted Average Shares | 5.02M | ||
| Weighted Average Shares Diluted | 5.02M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.81M | ||
| Cash and Equivalents (USD) | 8.81M | ||
| Current Assets | 9.30M | ||
| Property, Plant & Equipment Net | 318.47K | ||
| Total Assets | 9.62M | ||
| Current Liabilities | 7.57M | ||
| Total Liabilities | 23.64M | ||
| Accumulated Retained Earnings (Deficit) | -162.55M | ||
| Accumulated Other Comprehensive Income | -699.89K | ||
| Shareholders Equity | -14.03M | ||
| Shareholders Equity (USD) | -14.03M | ||
| Assets Non-Current | 318.47K | ||
| Liabilities Non-Current | 16.07M | ||
| Trade and Non-Trade Payables | 19.99M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 36.06K | ||
| Net Cash Flow from Financing | 1.37M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -718.70K | ||
| Issuance (Purchase) of Equity Shares | 1.37M | ||
| Net Cash Flow from Operations | -2.08M | ||
| Effect of Exchange Rate Changes on Cash | -2.04K | ||
| Share Based Compensation | 422.20K | ||